Freedom EV0-2 with any version of EVOware and EVOware Sample Tracking Add-On V1.0 or higher
FDA Device Recall #Z-3187-2018 — Class II — July 23, 2018
Recall Summary
| Recall Number | Z-3187-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 23, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Tecan US, Inc. |
| Location | Morrisville, NC |
| Product Type | Devices |
| Quantity | 19 EVOware Sample Tracking Software Add-on |
Product Description
Freedom EV0-2 with any version of EVOware and EVOware Sample Tracking Add-On V1.0 or higher
Reason for Recall
There is a software issue that can potentially impact sample identification and traceability under specific conditions when using EVOware Add On Software: Sample Tracking -Multi Instrument V1.0 or higher, Part Number 30019971.
Distribution Pattern
Nationwide distribution to CA, MA, NC, OH, TX, and VA. Worldwide distribution to Australia, Canada, China, EU, and Japan.
Lot / Code Information
Part Numbers for Models of Freedom EVO with any version of EVOware: a. Freedom EVO 100: 10641100, 30020010, 30032010; b. Freedom EVO 150: 10641150, 10641152, 30020015, 30032015; c. Freedom EVO 200 Base Unit: 10641200, 10641202, 30020020, 30032020; Part Numbers for Software: EVOware Sample Tracking Add-On for Multi¿ Instrument Configurations: 30019971; Serial Numbers for device: 1302001540, 1708006808, 1208007284, 1503007126, 1503007304, 905000588, 1205002755, 1205002802, 1305007607, 1308005431, 1310005144, 1310005145, 905000587, 1705007973, 904000335, 1510009082, 1109004352, 1704005194, 1007000504, 1305002594, 1307006551 and 1105004439.
Other Recalls from Tecan US, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1851-2019 | Class II | Freedom EVO 200 - Product Usage: It is intended... | Apr 12, 2019 |
| Z-2923-2018 | Class II | Cortisol Saliva Luminescence Immunoassay Th... | Jan 12, 2018 |
| Z-2660-2016 | Class II | Infinite F50 instrument. The INFINITE F50 inst... | Jul 25, 2016 |
| Z-2661-2016 | Class II | SUNRISE instrument. The INFINITE F50 instrumen... | Jul 25, 2016 |
| Z-2664-2016 | Class II | Tecan Infinite M1000 The Tecan Infinite M1000 ... | Jul 25, 2016 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.